Kesimpta was approved in August 2020 as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...

Kesimpta (ofatumumab) can be outside the refrigerator for up to 7 days. It’s important to store the drug correctly to ensure it stays safe and effective for you to use. Kesimpta (ofatumumab ...

Kesimpta Market Report 2025 The Business Research Company's Key Market Driver In Kesimpta Industry 2025: Increasing Multiple Sclerosis Prev ...

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

TG Therapeutics stock skyrocketed Monday after easily beating fourth-quarter sales expectations and issuing a bullish outlook for 2025.

On a constant currency basis, sales increased 16%, driven by the momentum in Entresto, Kesimpta, Kisqali, Cosentyx and Leqvio. The top line beat the Zacks Consensus Estimate of $12.97 billion.

He stated that the company has strong replacement power. Multiple sclerosis drug Kesimpta sales reached $950 million, up 49% at constant currency. Novartis said that sales grew across all regions ...